secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2026-01-27T23:59:59+00:00
Accession:  0001493152-26-003718
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo tender offer oversubscribed; 4.9M shares tendered, 300k accepted at $3.50 per share
--------------------------------------------------------------------------------

- 4,897,188 shares properly tendered (excluding 10,868 by guaranteed delivery).
- Company expects to accept 300,000 shares at $3.50 each for total cost of ~$1.05M.
- Proration factor approximately 3.51542%; odd lots accepted in full.
- Shares accepted represent about 0.73% of outstanding as of Jan 26, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315226003718/0001493152-26-003718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315226003718/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-003718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer